CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98027Q00044
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6640
Additional Details
Documents1
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions (OLAO), has issued a combined synopsis/solicitation for the procurement of commercial items under solicitation number 75N98027Q00044. This opportunity, titled "CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap)," seeks proposals from qualified vendors to provide an upgrade to the PExA 2.1 system, transitioning it to a vial-based configuration, referred to as the PExA Cap.
The primary objective of this procurement is to enhance the existing PExA 2.1 analytical laboratory instrument by upgrading its sample collection mechanism to a vial-based system. This upgrade is expected to improve the efficiency, reliability, and usability of the instrument, which is likely used for advanced particle or aerosol analysis in a laboratory setting. The intended outcome is to ensure that the NIH has access to state-of-the-art analytical capabilities to support its ongoing research and operational needs.
Key requirements for this solicitation include the provision of all necessary commercial products or services to complete the upgrade, in accordance with the specifications outlined in the solicitation and any attached documentation. The successful contractor will be responsible for delivering a fully functional, vial-based PExA Cap system, ensuring compatibility with the existing PExA 2.1 platform. Deliverables are expected to include all hardware, software, installation, and any required training or documentation to support the upgraded system.
This procurement is classified under NAICS code 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees. However, the requirement is unrestricted, allowing for full and open competition among all qualified offerors, regardless of business size. The contract will be awarded as a Firm-Fixed-Price (FFP) purchase order, with the selection based on best value to the Government.
The solicitation is issued in accordance with Federal Acquisition Regulation (FAR) Subpart 12.6 and FAR 12.603, utilizing streamlined procedures for commercial products and services. All applicable provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, dated March 13, 2026.
Interested parties should note that this is the only solicitation being issued; no separate written solicitation will follow. Proposals must be submitted by the response deadline of November 12, 2026, at 2:11 PM. The notice remains active and can be accessed via the SAM.gov portal at the provided URL.
The primary point of contact for this procurement is Nicholas S. Capobianco, who can be reached via email at [email protected]. The contracting activity is managed by the NIH OLAO, under the Department of Health and Human Services.
Contractors considering this opportunity should ensure their capabilities align with the requirements for upgrading analytical laboratory instruments, particularly in the context of vial-based sample collection systems. The scope, technical requirements, and deliverables are expected to remain consistent throughout the contract lifecycle, focusing on the successful transition of the PExA 2.1 system to the enhanced PExA Cap configuration.